TenSixty Bio
PrivateLast Round
Seed
Aug 24, 2022
Total Funding Raised
$7.2M
Company Overview
TenSixty Bio operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in August 2022.
TenSixty Bio is a biotechnology company that develops an epitope discovery platform to advance the development of antibody therapeutics for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TenSixty Bio Comparables
Compare TenSixty Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stipple Bio | 78% | |
| Alithea Biotechnology GmbH | 77% | |
| LabGenius Therapeutics | 75% |
For institutional investors. Book with your work email.
TenSixty Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TenSixty Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Engine | Seed |
| General Catalyst | Seed |
| Wing Venture Capital | Seed |
| Civilization Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2022
$7.2M round led by Venture Highway.
For institutional investors. Book with your work email.
TenSixty Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TenSixty Bio's valuation, stock price, and market status.
Is TenSixty Bio a public or private company?
TenSixty Bio is a private company.
What is the current stock price of TenSixty Bio?
TenSixty Bio is a private company, so its shares have no public market price. Caplight tracks TenSixty Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TenSixty Bio worth (valuation)?
Valuation information for TenSixty Bio is not publicly available.
Can I buy TenSixty Bio stock?
TenSixty Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TenSixty Bio's last funding round?
TenSixty Bio's most recent funding round was Seed on August 24, 2022.
Who are the main investors in TenSixty Bio?
Key investors in TenSixty Bio include The Engine, General Catalyst, Wing Venture Capital, Civilization Ventures.
Will TenSixty Bio IPO soon?
No public IPO plans have been announced for TenSixty Bio.
How can I track TenSixty Bio secondary market activity?
Caplight tracks bids, offers, and trades in TenSixty Bio's shares on secondary markets.